These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11477100)
1. 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. Li L; Tao J; Davaille J; Feral C; Mallat A; Rieusset J; Vidal H; Lotersztajn S J Biol Chem; 2001 Oct; 276(41):38152-8. PubMed ID: 11477100 [TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells. Date M; Fukuchi K; Morita S; Takahashi H; Ohura K Liver Int; 2003 Dec; 23(6):460-6. PubMed ID: 14986820 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153 [TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. Guyton K; Bond R; Reilly C; Gilkeson G; Halushka P; Cook J J Leukoc Biol; 2001 Apr; 69(4):631-8. PubMed ID: 11310850 [TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells. Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891 [TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms. Ray DM; Akbiyik F; Phipps RP J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690 [TBL] [Abstract][Full Text] [Related]
9. Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-gamma. Erl W; Weber C; Zernecke A; Neuzil J; Vosseler CA; Kim HJ; Weber PC Eur J Immunol; 2004 Jan; 34(1):241-50. PubMed ID: 14971050 [TBL] [Abstract][Full Text] [Related]
10. Physiological and Pathological Roles of 15-Deoxy-Δ Yagami T; Yamamoto Y; Koma H Mol Neurobiol; 2018 Mar; 55(3):2227-2248. PubMed ID: 28299574 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells. Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252 [TBL] [Abstract][Full Text] [Related]
12. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells. Siavash H; Nikitakis NG; Sauk JJ Cancer Lett; 2004 Jul; 211(1):97-103. PubMed ID: 15194221 [TBL] [Abstract][Full Text] [Related]
16. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774 [TBL] [Abstract][Full Text] [Related]
17. A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. Shan ZZ; Masuko-Hongo K; Dai SM; Nakamura H; Kato T; Nishioka K J Biol Chem; 2004 Sep; 279(36):37939-50. PubMed ID: 15213234 [TBL] [Abstract][Full Text] [Related]
18. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Collin M; Patel NS; Dugo L; Thiemermann C Crit Care Med; 2004 Mar; 32(3):826-31. PubMed ID: 15090969 [TBL] [Abstract][Full Text] [Related]
19. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation. Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573 [TBL] [Abstract][Full Text] [Related]